期刊文献+

HPLC法检测人血浆中喷昔洛韦浓度及其药代动力学研究

HPLC determination of penciclovir in human plasma and its pharmacokinetic study
原文传递
导出
摘要 目的:建立测定人体血浆中喷昔洛韦高效液相色谱法,并测定健康志愿者口服泛昔洛韦片12h内血药浓度。方法:采用6%高氯酸直接沉淀提取血浆,色谱柱为C18(250mm×4.6mm,5μm),0.4%磷酸-甲醇(95∶5)为流动相,流速0.8mL·min-1,荧光检测波长为λex=270nm,λem=375nm。结果:喷昔洛韦本法线性范围为0.05~5μg·mL-1(r=0.9999,n=7);最低定量限0.05μg·mL-1;低、中、高3种浓度的平均回收率分别为(97.80±2.28)%,(96.60±0.37)%,(96.58±0.38)%;日内、日间精密度RSD均<4%。结论:本检测方法简便、快速、经济、准确,可用于测定人血浆中喷昔洛韦的浓度。 Objective:To establish an HPLC method for the determination of penciclovir in human plasma,and to determine the concentration of penciclovir in human plasma after oral of famciclovir tablets into healthy volunteers within 12 hours.Methods:The penciclovir was extracted from plasma by 6% perchloric acid.Chromatographic separation has been achieved on C18 column(250 mm×4.6 mm,5 μm) with 0.4% phosphoric acid-methanol(95∶5)as the mobile phase at a flow rate of 0.8 mL·min-1;The fluorescence detection at λex=270 nm and λem=375 nm.Results:The linear range was 0.05-5 μg·mL-1(r=0.9999,n=7).The minimum ration limit was 0.05 μg·mL-1.The average recoveries of low,middle and high concentration were (97.80±2.28)%,(96.60±0.37)% and (96.58±0.38)%,RSDs of inter and intra-day precisions were less than 4%.Conclution:The method is simple,rapid,economic and accurate for determination of penciclovir in human plasma.
出处 《药物分析杂志》 CAS CSCD 北大核心 2009年第12期2007-2009,共3页 Chinese Journal of Pharmaceutical Analysis
关键词 喷昔洛韦 高效液相色谱法 血浆 penciclovir HPLC plasma
  • 相关文献

参考文献5

二级参考文献16

  • 1张婷婷,李铜铃,孙健,陈束叶,张洁,黄婷,杨岚.泛昔洛韦分散片在人体内的生物等效性[J].华西药学杂志,2006,21(3):260-262. 被引量:5
  • 2Gill KS, Wood MJ. The clinical pharmacokinetics of famciclovir Clin[J]. Pharmacokinet, 1996,31(1): 1 - 8.
  • 3Steven C Boike, Martin Pue, Patricia R Audet, et al. Pharmacokinetics of famcilovir in subjects with chromic hepatic disease [ J]. J Clin Pharmacol, 1994,34(12) : 1199 - 1207.
  • 4McMeekin JR, Fowles SE, Winton CF, et al. Rapid high performance liquid chromatographic method for the analysis of the active antiherpes agent penciclovir and its precursor. BRL.42359, in human plasma and urine following administration of the oral prodrug, famciclovir [J].Anal Proc, 1992,29: 178- 180.
  • 5Msscher H, Kikuta C. New high - senditivity HPLC method for the determination of acyclovir in human plasma, Using fluorometric detection[J] .J Chromatogy, 1992,583:122 - 127.
  • 6McMeekin JR, Fowles SE, Winton CF, et al. Rapid high performance liquid chromatographic method for the analysis of the active antiherpes agent penciclovir' and its precursor, BRL 42359, in human plasma and urine follow administration of theoral prodrug, famciclovir[J].Anal Proc, 1992,29:178-186.
  • 7Bioke SC, Pue M, Audet PR,et al. Pharmacokinetics of famciclovir in subjects with chronic hepatic disease[J]. J Clin Pharmacol, 1994,34( 12 ) : 1199-1207.
  • 8Hsu LC, Constable DJ, Orvos DR, et al. Comparison of high performance liquid chromatography and capillary zone electrophoresis in penciclovir blodegradation kinetic studies [J].J Chromatogr B Biomed Appl, 1995,669( 1 ) : 85-92.
  • 9Causon R. Validation of chromatographic methods in biomedical analysis[J]. J Chromatogr B, 1997,689:175-180.
  • 10McMeekin JR,Fowles SE,Winton CF,et al.Rapid highperformance liquid chromatographic method for the analysis of the active antiherpes agent penciclovir and its precursor, BRL 42359, in human plasma and urine following administration of the oral prodrug, famciclovir[].Analytical Proceedings.1992

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部